Is CRISPR Therapeutics AG technically bullish or bearish?

As of 31 October 2025, the technical trend for CRISPR Therapeutics AG has changed from mildly bullish to bullish. The weekly and monthly MACD indicators are both bullish, supporting a positive outlook. While the Bollinger Bands indicate a mildly bullish stance on both weekly and monthly time frames, the daily moving averages show a mildly bullish trend. However, the KST and Dow Theory present a mixed picture, with weekly signals being mildly bearish and monthly signals bullish. The stock has underperformed the S&P 500 over the past week and month, with returns of -14.17% and -16.73% compared to the S&P 500's gains of 0.71% and 1.92%, respectively. Despite this recent underperformance, the year-to-date return of 43.32% significantly outpaces the S&P 500's 16.30%. Overall, the current technical stance is bullish, albeit with some caution due to mixed indicators.